Stockreport

Hims & Hers defended at BofA as Lilly fights compounded GLP-1s [Seeking Alpha]

Hims & Hers Health, Inc. Class A  (HIMS) 
PDF America on Thursday defended Hims & Hers Health ( NYSE: HIMS ), which recently announced a similar product line and sold off on the news. Last month, the San Francisco [Read more]